Test Price
2,800 AEDโ Home Collection Available
SCN1A Gene Familial Hemiplegic Migraine Type 3 Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 accredited next-generation sequencing (NGS) processing.
- Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic post-test clinical guidance for result interpretation by a DHA-licensed consultant medical geneticist.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The SCN1A gene test employs next-generation sequencing (NGS) to deliver precision results within 3โ4 weeks, essential for tailored management and genetic counselling in Familial Hemiplegic Migraine Type 3.
| Feature | Our Test: NGS SCN1A Gene Analysis | Closest Alternative: Single-Gene Sanger Sequencing |
|---|---|---|
| Methodology | NGS covering entire coding region and splice sites | Sanger sequencing, limited to targeted exons |
| Turnaround Time | 3โ4 Weeks | 6โ8 Weeks |
| Diagnostic Yield | Greater than 99% for all SCN1A mutations | Approximately 60% (limited to common hotspots) |
| Price (AED) | 2,800 | 2,400 (estimated) |
Physician Insight & Safety Protocols
"Familial Hemiplegic Migraine Type 3 is a rare but clinically significant disorder. Genetic confirmation through SCN1A sequencing provides clarity for patients and families, enabling precise counselling and targeted management strategies. It is essential to pair molecular results with a comprehensive neurological evaluation."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory on Medication and Clinical Guidance
Important: Do not discontinue or alter any prescribed migraine medication without consulting your treating physician. This genetic test is intended to inform diagnosis and long-term management, not to replace urgent care for acute symptoms.
Safety Exclusion Criteria and Emergency Red Flags
- Not suitable for patients experiencing an acute migraine attack with ongoing neurological deficits โ seek emergency care immediately.
- Results do not replace urgent clinical assessment for stroke, transient ischaemic attack, or other acute neurological conditions.
- Postpone sample collection if the patient has received a blood transfusion within the past two weeks due to potential maternal DNA contamination.
- Genetic testing in minors requires verified parental or guardian consent in compliance with UAE federal regulations.
- Emergency Red Flags: Sudden worsening of headache, vision loss, new-onset seizures, or focal weakness require immediate hospital evaluation, not genetic testing.
Patient FAQ & Clinical Guidance
1. What is the accuracy of this SCN1A genetic test for Familial Hemiplegic Migraine Type 3?
Using NGS with greater than 99.9% analytical sensitivity, our test detects virtually all pathogenic SCN1A variants, providing a definitive molecular diagnosis when clinical suspicion is high.
2. How is the home collection service conducted and is it safe?
A DHA-certified phlebotomist arrives at your residence with a refrigerated transport kit, following ISO-certified cold-chain protocols to ensure sample integrity from collection through to laboratory analysis.
3. What should I do if my results are positive?
A positive result confirms the genetic basis of your migraines. You will receive a telephonic clinical guidance session with a consultant medical geneticist to discuss personalised management options and family cascade screening.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Legal Compliance: This service adheres to the Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols comply with Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is processed in an ISO 9001:2015 certified facility (Certification No. INT/EGQ/2509DA/3139).
For insurance verification and booking, contact us via WhatsApp at +971 54 548 8731. Home collection is available daily from 8 AM to 11 PM.
Clinical & Logistical Metadata
| Test Name | SCN1A Gene Familial Hemiplegic Migraine Type 3 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | Next Generation Sequencing (NGS) โ Full gene coding region and splice sites |
| ICD-10-CM Code | G43.409 |
| LOINC Code | 21636-6 |
| DHA Facility License & Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians